These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23670614)

  • 1. Risk factors: intestinal microbiota: "a new direction in cardiovascular research".
    Lim GB
    Nat Rev Cardiol; 2013 Jul; 10(7):363. PubMed ID: 23670614
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut microbiota, the genome, and diet in atherogenesis.
    Loscalzo J
    N Engl J Med; 2013 Apr; 368(17):1647-9. PubMed ID: 23614591
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
    Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
    N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flagging flora: heart disease link.
    Davidson S
    Nature; 2011 Sep; 477(7363):162. PubMed ID: 21900997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intestinal microbiota: from antibiotic-associated diarrhea to inflammatory bowel diseases].
    Quévrain E; Seksik P
    Presse Med; 2013 Jan; 42(1):45-51. PubMed ID: 23260759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
    Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL
    Nat Med; 2013 May; 19(5):576-85. PubMed ID: 23563705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.
    Drosos I; Tavridou A; Kolios G
    Metabolism; 2015 Apr; 64(4):476-81. PubMed ID: 25676802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota produced trimethylamine-N-oxide can increase the risk of cardiovascular disease.
    Khan MS; Bawany FI; Khan A
    J Pak Med Assoc; 2014 Apr; 64(4):488. PubMed ID: 24864657
    [No Abstract]   [Full Text] [Related]  

  • 9. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special issue: The Human Intestinal Microbiota.
    Flint HJ; O'Toole PW; Walker AW
    Microbiology (Reading); 2010 Nov; 156(Pt 11):3203-3204. PubMed ID: 21045216
    [No Abstract]   [Full Text] [Related]  

  • 11. You Are What You Eat: Metabolites of Gut Microbiota Provide Novel Insights into Diagnosis and Development of Chronic Kidney Disease.
    Quante M
    Transplantation; 2015 Jul; 99(7):1306-7. PubMed ID: 26147133
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.
    Natividad JM; Verdu EF
    Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenome and metabolism: the tissue microbiota hypothesis.
    Burcelin R; Serino M; Chabo C; Garidou L; Pomié C; Courtney M; Amar J; Bouloumié A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():61-70. PubMed ID: 24003922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution.
    Stecher B; Maier L; Hardt WD
    Nat Rev Microbiol; 2013 Apr; 11(4):277-84. PubMed ID: 23474681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The developing intestinal microbiome and its relationship to health and disease in the neonate.
    Murgas Torrazza R; Neu J
    J Perinatol; 2011 Apr; 31 Suppl 1():S29-34. PubMed ID: 21448201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota is a plastic factor responding to environmental changes.
    Candela M; Biagi E; Maccaferri S; Turroni S; Brigidi P
    Trends Microbiol; 2012 Aug; 20(8):385-91. PubMed ID: 22672911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interactions between intestinal microbiota and intestinal macrophages on health.
    Nakata K; Yamamoto M; Inagawa H; Soma G
    Anticancer Res; 2013 Jul; 33(7):2849-53. PubMed ID: 23780969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease: the diet-microbe morbid union.
    Rak K; Rader DJ
    Nature; 2011 Apr; 472(7341):40-1. PubMed ID: 21475185
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine.
    Stremmel W; Schmidt KV; Schuhmann V; Kratzer F; Garbade SF; Langhans CD; Fricker G; Okun JG
    PLoS One; 2017; 12(1):e0170742. PubMed ID: 28129384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal microbiota, obesity and insulin resistance].
    Pernet A; Petriccioli N
    Rev Med Suisse; 2011 Nov; 7(317):2236-8. PubMed ID: 22400352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.